SCHEDULE 13G/A

Enanta Pharmaceuticals Inc

Common Stock, par value $0.01 per share (the "Shares") · CUSIP: 29251M106

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Farallon Capital Partners, L.P.

  Shares: 395,700 · Class: 1.9%

• Farallon Capital Institutional Partners, L.P.

  Shares: 464,400 · Class: 2.2%

• Farallon Capital Institutional Partners II, L.P.

  Shares: 108,700 · Class: 0.5%

• Farallon Capital Institutional Partners III, L.P.

  Shares: 58,500 · Class: 0.3%

• Four Crossings Institutional Partners V, L.P.

  Shares: 74,800 · Class: 0.4%

• Farallon Capital Offshore Investors II, L.P.

  Shares: 822,766 · Class: 3.9%

• Farallon Capital (AM) Investors, L.P.

  Shares: 42,200 · Class: 0.2%

• Farallon Capital F5 Master I, L.P.

  Shares: 141,196 · Class: 0.7%

• Farallon Partners, L.L.C.

  Shares: 1,967,066 · Class: 9.3%

• Farallon Institutional (GP) V, L.L.C.

  Shares: 74,800 · Class: 0.4%

• Farallon F5 (GP), L.L.C.

  Shares: 141,196 · Class: 0.7%

• Dapice Joshua J.

  Shares: 2,108,262 · Class: 9.9%

• Dreyfuss, Philip D.

  Shares: 2,108,262 · Class: 9.9%

• Dunn Hannah E.

  Shares: 2,108,262 · Class: 9.9%

• Fried, Richard B

  Shares: 2,108,262 · Class: 9.9%

• Gehani, Varun N.

  Shares: 2,108,262 · Class: 9.9%

• Giauque, Nicolas

  Shares: 2,108,262 · Class: 9.9%

• Kim, David T.

  Shares: 2,108,262 · Class: 9.9%

• Linn, Michael G.

  Shares: 2,108,262 · Class: 9.9%

• Luo Patrick (Cheng)

  Shares: 2,108,262 · Class: 9.9%

• Patel, Rajiv A.

  Shares: 2,108,262 · Class: 9.9%

• Roberts, Jr., Thomas G.

  Shares: 2,108,262 · Class: 9.9%

• Saito Edric C.

  Shares: 2,108,262 · Class: 9.9%

• Seybold, William

  Shares: 2,108,262 · Class: 9.9%

• Short Daniel S.

  Shares: 2,108,262 · Class: 9.9%

• Spokes, Andrew J. M.

  Shares: 2,108,262 · Class: 9.9%

• Warren, John R.

  Shares: 2,108,262 · Class: 9.9%

• Wehrly, Mark C.

  Shares: 2,108,262 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.